Rydex Health Care Fund Class C RYHCX

Morningstar Medalist Rating
  • NAV / 1-Day Return$110.25  /  −1.15%
  • Fund Size$27.6M
  • Adjusted Expense Ratio2.400%
  • Net Expense Ratio2.400%
  • Fee Level: DistributionHigh
  • Share Class TypeLevel Load
  • Morningstar CategoryHealth
  • Equity Style Box (Funds)Mid Value
  • Minimum Initial Investment$2,500
  • Investment StatusOpen
  • TTM Yield0.00%
  • Turnover Ratio244%

Morningstar’s Analysis RYHCX

Will RYHCX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Rydex Health Care C holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings RYHCX

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings24.2
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

4.09872,438
Healthcare

Johnson & Johnson

3.24690,707
Healthcare

AbbVie Inc

2.81599,826
Healthcare

Merck & Co Inc

2.46525,005
Healthcare

UnitedHealth Group Inc

2.26482,710
Healthcare

Thermo Fisher Scientific Inc

2.16461,059
Healthcare

Amgen Inc

2.06440,478
Healthcare

Gilead Sciences Inc

1.78379,183
Healthcare

Pfizer Inc

1.67356,728
Healthcare

Abbott Laboratories

1.64350,056
Healthcare

Sponsor Center